Cleared Traditional

K933713 - VENOUS RESERVIOR/CARDIOTOMY AUTOTRANSFUSION FILTER WITH DURAFLO II HEPARIN TREATMENT (FDA 510(k) Clearance)

Mar 1994
Decision
214d
Days
Class 2
Risk

K933713 is an FDA 510(k) clearance for the VENOUS RESERVIOR/CARDIOTOMY AUTOTRANSFUSION FILTER WITH DURAFLO II HEPARIN TREATMENT. This device is classified as a Reservoir, Blood, Cardiopulmonary Bypass (Class II - Special Controls, product code DTN).

Submitted by Baxter Healthcare Corp (Irvine, US). The FDA issued a Cleared decision on March 1, 1994, 214 days after receiving the submission on July 30, 1993.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.4400.

Submission Details

510(k) Number K933713 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 30, 1993
Decision Date March 01, 1994
Days to Decision 214 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement

Device Classification

Product Code DTN — Reservoir, Blood, Cardiopulmonary Bypass
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.4400